<DOC>
	<DOCNO>NCT01337544</DOCNO>
	<brief_summary>The investigator propose new antitumor cell therapy treat childhood refractory solid tumour . The aim study explore graft versus tumour effect mediate allogenic natural killer cell ( NKs ) . NK cell alloreactivity predict donor killer immunoglobulin-like receptor ( KIRs ) human leukocyte antigen ( HLA ) class I alleles mismatch . Cells without inhibitory HLA ligand may trigger natural killer cell activation elimination target cell . Reduced risk relapse described malignant cancer haploidentical stem cell transplantation HLA ligands inhibitory KIRs present donor absent recipient ( KIR-HLA receptor-ligand mismatch ) . NK alloreactivity could also obtain Natural Killer Receptor ( NCR ) , Toll-Like-Receptors ( TLRs ) NKG2D receptor stimulation mediate cytokine tumour cell line . This open , non randomize , Phase I/II clinical trial , double objective : therapeutic exploratory . The investigator aim study safety efficacy haploidentical stem cell transplantation treatment malignancy cure know . Patients receive haploidentical stem cell transplantation , follow IL-15 stimulate NK cell infusion one month transplantation . Efficacy procedure evaluate up-to-date radiological technique , molecular study functional assay .</brief_summary>
	<brief_title>Haploidentical Stem Cell Transplantation IL-15 NK Cell Infusion Paediatric Refractory Solid Tumours</brief_title>
	<detailed_description>The investigator propose new antitumor cell therapy treat childhood refractory solid tumour . The aim study explore graft versus tumour effect mediate allogenic natural killer cell ( NKs ) . NK cell alloreactivity predict donor killer immunoglobulin-like receptor ( KIRs ) human leukocyte antigen ( HLA ) class I alleles mismatch . Cells without inhibitory HLA ligand may trigger natural killer cell activation elimination target cell . Reduced risk relapse described malignant cancer haploidentical stem cell transplantation HLA ligands inhibitory KIRs present donor absent recipient ( KIR-HLA receptor-ligand mismatch ) . NK alloreactivity could also obtain Natural Killer Receptor ( NCR ) , Toll-Like-Receptors ( TLRs ) NKG2D receptor stimulation mediate cytokine tumour cell line .</detailed_description>
	<criteria>Age 6 month 22 year . Histological solid tumor confirmation . Measurable solid tumor image molecular technique . Solid tumor fail least 2 chemotherapy protocol . Suitable haploidentical donor available . Lansky score &gt; 60 % . Serum bilirubin &gt; 3 mg/dl GFR &lt; 40 ml/min/1.73 mw Cardiac leave ventricular ejection fraction &lt; 40 % HIV+ Pregnant Unfavorable psychosocial report . Antecedent abandonment treatment .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>22 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>HAPLOIDENTICAL STEM CELL TRANSPLANTATION</keyword>
	<keyword>NK CELL</keyword>
	<keyword>IL-15</keyword>
</DOC>